Skip to content
Inciteful Med

Building Your Care Team & Managing Critical Risks

Last updated:

Managing myotonic dystrophy requires a care team led by a neurologist, cardiologist, and pulmonologist. Patients face severe risks from heart arrhythmias, breathing weakness, and extreme sensitivity to anesthesia, making regular monitoring and a medical alert bracelet essential for safety.

Key Takeaways

  • • Myotonic dystrophy is a multisystemic disease requiring a multidisciplinary medical team beyond just a neurologist.
  • • Annual cardiac monitoring with an EKG and Holter monitor is critical to catch life-threatening, silent heart rhythm issues.
  • • Regular pulmonary function tests and sleep studies are necessary to track weakening breathing muscles and sleep apnea.
  • • Patients are extremely sensitive to anesthesia and sedatives, requiring specialized surgical protocols and a medical alert bracelet.
  • • A Speech-Language Pathologist can evaluate swallowing to prevent severe respiratory complications like aspiration pneumonia.

Because Myotonic Dystrophy is a multisystemic disease, a neurologist alone is not enough to manage your care [1]. You need a multidisciplinary team—a group of specialists who work together to monitor the different ways the condition can affect your body [2].

Cardiology: The Non-Negotiable

The most critical part of your care team is a cardiologist [3]. Myotonic Dystrophy can affect the “electrical wiring” of the heart, leading to conduction defects (signals moving too slowly) or arrhythmias (irregular heartbeats) [4]. These issues can be life-threatening and often have no symptoms until they become serious [5].

  • Annual EKG: A standard 12-lead EKG to check your heart’s rhythm [6].
  • 24-Hour Holter Monitor: Because a standard EKG only takes a few seconds, it can miss intermittent rhythm issues. A Holter monitor records your heart for a full day [4][6].
  • Echocardiogram (Echo): An ultrasound of the heart to check its physical structure and how well it pumps blood [6].
  • Prophylactic Devices: In some cases, doctors may recommend a pacemaker or ICD (Implantable Cardioverter Defibrillator) before symptoms become severe to prevent sudden cardiac events [7].

Pulmonology and Sleep Medicine

Respiratory failure is a leading cause of complication in DM [3]. As the diaphragm and other breathing muscles weaken, it becomes harder for the lungs to expand fully (known as restrictive lung disease) [8].

  • Pulmonary Function Tests (PFTs): These tests measure your Forced Vital Capacity (FVC)—the amount of air you can exhale. Monitoring this regularly helps your team know when you might need breathing support [9].
  • Sleep Studies: Many patients stop breathing periodically during sleep (sleep apnea) or do not breathe deeply enough (nocturnal hypoventilation) [10]. Symptoms like morning headaches or extreme daytime sleepiness are signs you may need a sleep study or a nighttime breathing machine like NIV (Non-Invasive Ventilation) [11][12].

The Anesthesia Warning: Critical Safety

Patients with Myotonic Dystrophy are extremely sensitive to general anesthesia, sedatives, and opioids [13]. These medications can cause your breathing to slow down dangerously or stop entirely, and they can trigger heart rhythm issues [13][14].

  • Medical Alert Card: You must carry a card or wear a bracelet stating you have Myotonic Dystrophy [15]. This is vital for emergency responders or surgeons who may not be familiar with your diagnosis.
  • Surgery Protocols: Any surgery, even “minor” ones, requires a specialized anesthesia plan. Always ensure your anesthesiologist is aware of your diagnosis well in advance [13].

Other Key Specialists

  • Neurology: Often acts as the “quarterback” of your team, monitoring muscle strength and managing medications for myotonia [1].
  • Speech-Language Pathology (SLP): Because trouble swallowing (dysphagia) is common, aspiration pneumonia (inhaling food or liquid into the lungs) is a leading cause of severe complications [16]. An SLP is critical for swallow evaluations and teaching airway protection strategies [12].
  • Maternal-Fetal Medicine (High-Risk Obstetrics): For patients who become pregnant, specialized obstetric care is mandatory [17]. DM1 pregnancies carry high risks of complications, including excess amniotic fluid (polyhydramnios), prolonged labor, and postpartum hemorrhage, as well as the risk of delivering an infant with severe Congenital DM1 [17][18].
  • Ophthalmology: Annual slit-lamp exams are necessary to check for “Christmas tree cataracts,” which can develop much earlier than typical age-related cataracts [19][20].
  • Endocrinology: Regular blood work is needed to screen for insulin resistance, diabetes, and thyroid issues, all of which are common comorbidities [21][22].

Frequently Asked Questions

Why do I need a cardiologist if I have myotonic dystrophy?
Myotonic dystrophy can affect the electrical wiring of your heart, causing irregular heartbeats or dangerously slow signals. A cardiologist will perform regular tests like an EKG and a 24-hour Holter monitor to catch these hidden, potentially life-threatening issues early.
Why is general anesthesia dangerous for myotonic dystrophy patients?
Patients with myotonic dystrophy are extremely sensitive to general anesthesia, sedatives, and opioids. These medications can dangerously slow or stop your breathing and trigger severe heart rhythm problems, requiring a highly specialized anesthesia plan for any surgery.
What breathing tests are necessary for managing my condition?
You should regularly have Pulmonary Function Tests (PFTs) to measure your Forced Vital Capacity, which tracks your breathing strength. Sleep studies are also crucial to check for sleep apnea or dangerously shallow breathing at night.
How does myotonic dystrophy affect swallowing and eating?
Muscle weakness can cause dysphagia, or trouble swallowing, which increases the risk of accidentally inhaling food or liquid into your lungs. A Speech-Language Pathologist can evaluate your swallowing and teach you strategies to eat safely and prevent pneumonia.
Should I wear a medical alert bracelet for myotonic dystrophy?
Yes, you must carry a medical alert card or wear a bracelet stating your diagnosis and your extreme sensitivity to anesthesia. This is vital to protect your safety in emergencies when first responders or doctors may not be familiar with your medical history.

Questions for Your Doctor

  • • Which cardiologist on my team has experience managing the specific conduction issues common in Myotonic Dystrophy?
  • • Can we schedule a baseline 24-hour Holter monitor and an echocardiogram, even if I have no heart symptoms?
  • • What is my current 'Forced Vital Capacity' (FVC), and how often will we repeat this test to monitor my breathing strength?
  • • In the event of an emergency surgery, what specific protocols will the anesthesia team follow to protect my breathing and heart?
  • • Can you refer me to a Speech-Language Pathologist for a swallow study to ensure I am eating safely?

Questions for You

  • • Do I have a medical alert bracelet or card that clearly states 'Myotonic Dystrophy: High Risk for Anesthesia'?
  • • Do I experience morning headaches or intense sleepiness during the day, which might mean I am not breathing well at night?
  • • Have I had a slit-lamp eye exam in the last year to check for early cataracts?
  • • Am I keeping a centralized folder of all my test results (EKGs, PFTs, Genetic Reports) to share with new doctors?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Myotonic dystrophy type 2: the 2020 update.

    Meola G

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):222-234 doi:10.36185/2532-1900-026.

    PMID: 33458578
  2. 2

    Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.

    Boentert M, Cao M, Mass D, et al.

    Respiration; international review of thoracic diseases 2020; (99(4)):360-368 doi:10.1159/000505634.

    PMID: 32299079
  3. 3

    Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

    Wu S, Prahlow JA

    The American journal of forensic medicine and pathology 2025; (46(4)):330-336 doi:10.1097/PAF.0000000000001073.

    PMID: 40928346
  4. 4

    Natural history of cardiac involvement in myotonic dystrophy type 1 - Emphasis on the need for lifelong follow-up.

    Petri H, Mohammad BJY, Kristensen AT, et al.

    International journal of cardiology 2024; (406()):132070 doi:10.1016/j.ijcard.2024.132070.

    PMID: 38643802
  5. 5

    Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort.

    Brunet Garcia L, Hajra A, Field E, et al.

    Frontiers in pediatrics 2022; (10()):910660 doi:10.3389/fped.2022.910660.

    PMID: 35757141
  6. 6

    Cardiac Pathology in Myotonic Dystrophy Type 1.

    Mahadevan MS, Yadava RS, Mandal M

    International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111874.

    PMID: 34769305
  7. 7

    Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.

    Russo V, Papa AA, Rago A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(7)):1148-1155 doi:10.1093/europace/euab282.

    PMID: 35861549
  8. 8

    Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study.

    Rossi S, Della Marca G, Ricci M, et al.

    Journal of the neurological sciences 2019; (399()):118-124 doi:10.1016/j.jns.2019.02.012.

    PMID: 30798109
  9. 9

    Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.

    Mazzoli M, Ariatti A, Garuti G, et al.

    Acta neurologica Belgica 2021; (121(1)):133-142 doi:10.1007/s13760-020-01425-z.

    PMID: 32651874
  10. 10

    Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies.

    Romigi A, Albanese M, Liguori C, et al.

    Journal of neurodegenerative diseases 2013; (2013()):692026 doi:10.1155/2013/692026.

    PMID: 26316996
  11. 11

    Excessive daytime sleepiness in myotonic dystrophy: a narrative review.

    Hoxhaj D, Pascazio A, Maestri M, et al.

    Frontiers in neurology 2024; (15()):1389949 doi:10.3389/fneur.2024.1389949.

    PMID: 39011358
  12. 12

    Adherence to Non-Invasive Ventilation in Steinert Disease: Clinical and Psychological Insights.

    Annunziata A, Simioli F, Polistina GE, et al.

    Brain sciences 2025; (15(9)) doi:10.3390/brainsci15090968.

    PMID: 41008328
  13. 13

    Complications After Dental Sedation: A Myotonic Mystery Case Report.

    Karamlou M, Asaria I, Barron J, et al.

    Anesthesia progress 2022; (69(4)):26-31 doi:10.2344/anpr-69-02-09.

    PMID: 36534775
  14. 14

    Myotonic Dystrophy.

    Hamel JI

    Continuum (Minneapolis, Minn.) 2022; (28(6)):1715-1734 doi:10.1212/CON.0000000000001184.

    PMID: 36537977
  15. 15

    Two cases of myotonic dystrophy manifesting various ophthalmic findings with genetic evaluation.

    Kang MJ, Yim HB, Hwang HB

    Indian journal of ophthalmology 2016; (64(7)):535-7 doi:10.4103/0301-4738.190157.

    PMID: 27609169
  16. 16

    High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

    Hilbert JE, Barohn RJ, Clemens PR, et al.

    Neurology 2017; (89(13)):1348-1354 doi:10.1212/WNL.0000000000004420.

    PMID: 28855409
  17. 17

    Maternal health and obstetric complications of genetic neuromuscular disorders in pregnancy: A systematic review.

    Ahmed HS, Teli A, Khullar K, Deepak BL

    European journal of obstetrics, gynecology, and reproductive biology 2025; (304()):152-170 doi:10.1016/j.ejogrb.2024.11.046.

    PMID: 39616806
  18. 18

    Clinical and genetic characteristics of childhood-onset myotonic dystrophy.

    Stokes M, Varughese N, Iannaccone S, Castro D

    Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.

    PMID: 31520483
  19. 19

    A Greek National Cross-Sectional Study on Myotonic Dystrophies.

    Papadimas GK, Papadopoulos C, Kekou K, et al.

    International journal of molecular sciences 2022; (23(24)) doi:10.3390/ijms232415507.

    PMID: 36555146
  20. 20

    Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1.

    Li M, Wang Z, Cui F, et al.

    Frontiers in neurology 2020; (11()):277 doi:10.3389/fneur.2020.00277.

    PMID: 32373051
  21. 21

    Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency.

    Takeshima K, Ariyasu H, Ishibashi T, et al.

    Endocrinology, diabetes & metabolism case reports 2018; (2018()) doi:10.1530/EDM-17-0143.

    PMID: 29367875
  22. 22

    Managing thyroid cancer in Steinert's disease: the role of radiofrequency ablation.

    Solis-Pazmino P, Carvajal MA, García M, et al.

    Journal of surgical case reports 2023; (2023(6)):rjad381 doi:10.1093/jscr/rjad381.

    PMID: 37397070

This page outlines standard care teams and medical risks for myotonic dystrophy for educational purposes only. Always consult your specialized healthcare team before undergoing any medical procedures or changing your care plan.

Stay up to date

Get notified when new research about Myotonic dystrophy is published.

No spam. Unsubscribe anytime.